Patrys Limited - Product Pipeline Review - 2015

Published: October 2015
No. of Pages: 45

Global Markets Direct’s, ‘Patrys Limited Product Pipeline Review 2015’, provides an overview of the Patrys Limited’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Patrys Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Patrys Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Patrys Limited’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Patrys Limited’s pipeline products

Reasons to buy

  • Evaluate Patrys Limited’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Patrys Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Patrys Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Patrys Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Patrys Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
  • Explore the dormant and discontinued projects of Patrys Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Patrys Limited - Product Pipeline Review - 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Patrys Limited Snapshot 5
Patrys Limited Overview 5
Key Information 5
Key Facts 5
Patrys Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Patrys Limited - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Patrys Limited - Pipeline Products Glance 11
Patrys Limited - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Patrys Limited - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Patrys Limited - Drug Profiles 15
PATSM-6 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PAT-SC1 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
PAT-LM1 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
PATNM-1 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
PATNM-3 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Antibodies for Cancer 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Cell Therapy for Cancer 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Monoclonal Antibodies for Cancer 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
PATH-12 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
PATSM-1 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
PATSM-3 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
PATSM-4 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
PATSM-5 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Patrys Limited - Pipeline Analysis 30
Patrys Limited - Pipeline Products by Target 30
Patrys Limited - Pipeline Products by Route of Administration 31
Patrys Limited - Pipeline Products by Molecule Type 32
Patrys Limited - Pipeline Products by Mechanism of Action 33
Patrys Limited - Recent Pipeline Updates 34
Patrys Limited - Dormant Projects 42
Patrys Limited - Locations And Subsidiaries 43
Head Office 43
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 44
Disclaimer 45

List of Tables

Patrys Limited, Key Information 5
Patrys Limited, Key Facts 5
Patrys Limited - Pipeline by Indication, 2015 8
Patrys Limited - Pipeline by Stage of Development, 2015 9
Patrys Limited - Monotherapy Products in Pipeline, 2015 10
Patrys Limited - Phase II, 2015 11
Patrys Limited - Phase I, 2015 12
Patrys Limited - Preclinical, 2015 13
Patrys Limited - Discovery, 2015 14
Patrys Limited - Pipeline by Target, 2015 30
Patrys Limited - Pipeline by Route of Administration, 2015 31
Patrys Limited - Pipeline by Molecule Type, 2015 32
Patrys Limited - Pipeline Products by Mechanism of Action, 2015 33
Patrys Limited - Recent Pipeline Updates, 2015 34
Patrys Limited - Dormant Developmental Projects,2015 42

List of Figures

Patrys Limited - Pipeline by Top 10 Indication, 2015 7
Patrys Limited - Pipeline by Stage of Development, 2015 9
Patrys Limited - Monotherapy Products in Pipeline, 2015 10
Patrys Limited - Pipeline by Top 10 Target, 2015 30
Patrys Limited - Pipeline by Top 10 Route of Administration, 2015 31
Patrys Limited - Pipeline by Top 10 Molecule Type, 2015 32
Patrys Limited - Pipeline Products by Top 10 Mechanism of Action, 2015 33

Published By: Global Markets Direct
Product Code: Global Markets Direct13272

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: